Genitourinary Cancer clinical trials at UC Irvine
2 research studies open to eligible people
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
open to eligible people ages 18 years and up
This is a phase 2a, randomized, double-blinded, placebo-controlled pilot clinical trial determining the impact of riluzole therapy on circulating brain derived neuropathic factor (BDNF) levels of cancer survivors with cancer related cognitive impairment.
Orange, California
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
open to eligible people ages 18 years and up
This is a phase II single-arm, Phase 2a, randomized, double-blinded, placebo-controlled pilot clinical trial determining efficacy of riluzole in preventing cognitive dysfunction in subjects with cancer, who are receiving chemotherapy.
Orange, California
Our lead scientists for Genitourinary Cancer research studies include Alexandre Chan.
Last updated: